These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33190924)

  • 1. Clinical and Histological Basis of Adenosquamous Carcinoma of the Pancreas: A 30-year Experience.
    Moslim MA; Lefton MD; Ross EA; Mackrides N; Reddy SS
    J Surg Res; 2021 Mar; 259():350-356. PubMed ID: 33190924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.
    Barnes CA; Aldakkak M; Christians KK; Clarke CN; Dua K; George B; Ritch PS; Kamgar M; Hall WA; Kulkarni N; Erickson BA; Evans DB; Tsai S
    Surgery; 2020 Sep; 168(3):440-447. PubMed ID: 32641278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
    Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
    Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients.
    Voong KR; Davison J; Pawlik TM; Uy MO; Hsu CC; Winter J; Hruban RH; Laheru D; Rudra S; Swartz MJ; Nathan H; Edil BH; Schulick R; Cameron JL; Wolfgang CL; Herman JM
    Hum Pathol; 2010 Jan; 41(1):113-22. PubMed ID: 19801164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: a Phase II pilot study.
    Jensen EH; Armstrong L; Lee C; Tuttle TM; Vickers SM; Sielaff T; Greeno EW
    HPB (Oxford); 2014 Feb; 16(2):131-9. PubMed ID: 23509924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI.
    Erstad DJ; Sojoodi M; Taylor MS; Jordan VC; Farrar CT; Axtell AL; Rotile NJ; Jones C; Graham-O'Regan KA; Ferreira DS; Michelakos T; Kontos F; Chawla A; Li S; Ghoshal S; Chen YI; Arora G; Humblet V; Deshpande V; Qadan M; Bardeesy N; Ferrone CR; Lanuti M; Tanabe KK; Caravan P; Fuchs BC
    Clin Cancer Res; 2020 Sep; 26(18):5007-5018. PubMed ID: 32611647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity.
    Trikudanathan G; Dasanu CA
    South Med J; 2010 Sep; 103(9):903-10. PubMed ID: 20697320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
    Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
    Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Adenosquamous Carcinoma: Experience Within an Integrated Health Care System.
    Kwak HV; Hsu DS; Chang A; Kazantsev GB; Peng PD; Spitzer AL; Chang CK
    Perm J; 2023 Jun; 27(2):9-12. PubMed ID: 36336674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial.
    Golcher H; Brunner TB; Witzigmann H; Marti L; Bechstein WO; Bruns C; Jungnickel H; Schreiber S; Grabenbauer GG; Meyer T; Merkel S; Fietkau R; Hohenberger W
    Strahlenther Onkol; 2015 Jan; 191(1):7-16. PubMed ID: 25252602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
    Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
    J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.
    Komatsu H; Egawa S; Motoi F; Morikawa T; Sakata N; Naitoh T; Katayose Y; Ishida K; Unno M
    Surg Today; 2015 Mar; 45(3):297-304. PubMed ID: 24973941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of multimodal therapy in the management of nonmetastatic adenosquamous carcinoma of the pancreas: Analysis of treatment sequence and strategy.
    Hue JJ; Katayama E; Sugumar K; Winter JM; Ammori JB; Rothermel LD; Hardacre JM; Ocuin LM
    Surgery; 2021 May; 169(5):1102-1109. PubMed ID: 33376004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
    Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
    Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcome of adenosquamous carcinoma of the pancreas.
    Okabayashi T; Hanazaki K
    World J Gastroenterol; 2008 Nov; 14(44):6765-70. PubMed ID: 19058301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosquamous carcinoma of the pancreas.
    Hsu JT; Yeh CN; Chen YR; Chen HM; Hwang TL; Jan YY; Chen MF
    Digestion; 2005; 72(2-3):104-8. PubMed ID: 16172546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas.
    Hoffman JP; Weese JL; Solin LJ; Engstrom P; Agarwal P; Barber LW; Guttmann MC; Litwin S; Salazar H; Eisenberg BL
    Am J Surg; 1995 Jan; 169(1):71-7; discussion 77-8. PubMed ID: 7818001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.